APOA1 and porphyria: Hepatocyte transduction with rAAV2/5-HMBS restores liver enzyme activity [38], while short-term administration of Ins-ApoAI also alleviates porphyria-associated symptoms by inducing ApoAI-mediated hepatic mitochondrial biogenesis [35].